Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$619

Avg closing price
Price range

2 Joel Greenblatt Pieris Pharmaceuticals Trades

Joel Greenblatt started to build up the position in Pieris Pharmaceuticals in Q1 2018. Since then they sold 457 shares. The investor sold all their shares in Q2 2018 and doesn't own any shares in Pieris Pharmaceuticals anymore.

Avg closing price
Price range
Sold -457 shares Q2 2018
Avg closing price $475.86
Price range $402.40 - $550.40
New holding (+457 shares) Q1 2018
Avg closing price $619.00
Price range $544.00 - $756.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!